These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 16159155)

  • 1. Chemistry and structural biology of androgen receptor.
    Gao W; Bohl CE; Dalton JT
    Chem Rev; 2005 Sep; 105(9):3352-70. PubMed ID: 16159155
    [No Abstract]   [Full Text] [Related]  

  • 2. Androgens and pharmacology.
    Haendler B
    Andrologia; 2005 Dec; 37(6):213-5. PubMed ID: 16336252
    [No Abstract]   [Full Text] [Related]  

  • 3. Regulation of androgen action.
    Roy AK; Lavrovsky Y; Song CS; Chen S; Jung MH; Velu NK; Bi BY; Chatterjee B
    Vitam Horm; 1999; 55():309-52. PubMed ID: 9949684
    [No Abstract]   [Full Text] [Related]  

  • 4. Circumventing anti-androgen resistance by molecular design.
    McGinley PL; Koh JT
    J Am Chem Soc; 2007 Apr; 129(13):3822-3. PubMed ID: 17348658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The androgen receptor: an overview.
    Zhou ZX; Wong CI; Sar M; Wilson EM
    Recent Prog Horm Res; 1994; 49():249-74. PubMed ID: 8146426
    [No Abstract]   [Full Text] [Related]  

  • 6. Androgens and prostate cancer: biology, pathology and hormonal therapy.
    Galbraith SM; Duchesne GM
    Eur J Cancer; 1997 Apr; 33(4):545-54. PubMed ID: 9274433
    [No Abstract]   [Full Text] [Related]  

  • 7. Molecular biology of the androgen responses.
    Claessens F; Verrijdt G; Haelens A; Callewaert L; Moehren U; d'Alesio A; Tanner T; Schauwaers K; Denayer S; Van Tilborgh N
    Andrologia; 2005 Dec; 37(6):209-10. PubMed ID: 16336250
    [No Abstract]   [Full Text] [Related]  

  • 8. Structural characterization of the human androgen receptor ligand-binding domain complexed with EM5744, a rationally designed steroidal ligand bearing a bulky chain directed toward helix 12.
    Cantin L; Faucher F; Couture JF; de Jésus-Tran KP; Legrand P; Ciobanu LC; Fréchette Y; Labrecque R; Singh SM; Labrie F; Breton R
    J Biol Chem; 2007 Oct; 282(42):30910-9. PubMed ID: 17711855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular modelling of the androgen receptor axis: rational basis for androgen receptor intervention in androgen-independent prostate cancer.
    Fletterick RJ
    BJU Int; 2005 Dec; 96 Suppl 2():2-9. PubMed ID: 16359432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unexpected binding orientation of bulky-B-ring anti-androgens and implications for future drug targets.
    Duke CB; Jones A; Bohl CE; Dalton JT; Miller DD
    J Med Chem; 2011 Jun; 54(11):3973-6. PubMed ID: 21506597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitors of androgen receptor activation function-2 (AF2) site identified through virtual screening.
    Axerio-Cilies P; Lack NA; Nayana MR; Chan KH; Yeung A; Leblanc E; Guns ES; Rennie PS; Cherkasov A
    J Med Chem; 2011 Sep; 54(18):6197-205. PubMed ID: 21846139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonsteroidal selective androgen receptors modulators (SARMs): designer androgens with flexible structures provide clinical promise.
    Brown TR
    Endocrinology; 2004 Dec; 145(12):5417-9. PubMed ID: 15545403
    [No Abstract]   [Full Text] [Related]  

  • 13. Molecular action of androgen in the normal and neoplastic prostate.
    Kokontis JM; Liao S
    Vitam Horm; 1999; 55():219-307. PubMed ID: 9949683
    [No Abstract]   [Full Text] [Related]  

  • 14. Co-activator and co-repressor interplay on the human androgen receptor.
    Papaioannou M; Reeb C; Asim M; Dotzlaw H; Baniahmad A
    Andrologia; 2005 Dec; 37(6):211-2. PubMed ID: 16336251
    [No Abstract]   [Full Text] [Related]  

  • 15. A polyaromatic receptor with high androgen affinity.
    Yamashina M; Tsutsui T; Sei Y; Akita M; Yoshizawa M
    Sci Adv; 2019 Apr; 5(4):eaav3179. PubMed ID: 31016239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of crystal structures of human androgen receptor ligand-binding domain complexed with various agonists reveals molecular determinants responsible for binding affinity.
    Pereira de Jésus-Tran K; Côté PL; Cantin L; Blanchet J; Labrie F; Breton R
    Protein Sci; 2006 May; 15(5):987-99. PubMed ID: 16641486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of androgen receptor action.
    Li J; Al-Azzawi F
    Maturitas; 2009 Jun; 63(2):142-8. PubMed ID: 19372015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of E/Z isomerization in a series of novel non-ligand binding pocket androgen receptor antagonists.
    Blanco F; Egan B; Caboni L; Elguero J; O'Brien J; McCabe T; Fayne D; Meegan MJ; Lloyd DG
    J Chem Inf Model; 2012 Sep; 52(9):2387-97. PubMed ID: 22853713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgen action: molecular mechanism and medical application.
    Liao S
    J Formos Med Assoc; 1994 Sep; 93(9):741-51. PubMed ID: 7735002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological options for treatment of hyperandrogenic disorders.
    Reismann P; Likó I; Igaz P; Patócs A; Rácz K
    Mini Rev Med Chem; 2009 Aug; 9(9):1113-26. PubMed ID: 19689407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.